(Q54766469)

3 June 2018

title

The distinction between coronary and myocardial reperfusion after thrombolytic therapy by clinical markers of reperfusion. (English)

1 reference

3 June 2018

1 reference

Matetzky S

1

1 reference

3 June 2018

Freimark D

2

1 reference

3 June 2018

Chouraqui P

3

1 reference

3 June 2018

Novikov I

4

1 reference

3 June 2018

Agranat O

5

1 reference

3 June 2018

Rabinowitz B

6

1 reference

3 June 2018

Kaplinsky E

7

1 reference

3 June 2018

Hod H

8

1 reference

3 June 2018

language of work or name

English

0 references

publication date

1 November 1998

1 reference

3 June 2018

Journal of the American College of Cardiology

published in

1 reference

3 June 2018

volume

32

1 reference

3 June 2018

issue

5

1 reference

3 June 2018

page(s)

1326-1330

1 reference

3 June 2018

Scintigraphic evidence of the "no reflow" phenomenon in human beings after coronary thrombolysis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

Progressive failure of coronary flow during reperfusion of myocardial infarction: documentation of the no reflow phenomenon with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

Ability of the no-reflow phenomenon during an acute myocardial infarction to predict left ventricular dysfunction at one-month follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

Noninvasive detection of coronary artery patency using continuous ST-segment monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue-type plasminogen activator): results of the Israeli Study of Early Intervention in Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

ST-segment analysis: a useful marker for reperfusion after thrombolysis with APSAC? The Belgian EMS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

Assessment of coronary artery patency after thrombolytic therapy: accurate prediction utilizing the combined analysis of three noninvasive markers

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

Angiographic validation of bedside markers of reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

Effects of nonsurgical myocardial reperfusion on plasma creatine kinase kinetics in man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

Patterns of creatine kinase release during acute myocardial infarction after nonsurgical reperfusion: comparison with conventional treatment and correlation with infarct size

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

Peak creatine kinase as a measure of effectiveness of thrombolytic therapy in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

Analysis of creatine kinase, CK-MB, myoglobin, and troponin T time-activity curves for early assessment of coronary artery reperfusion after intravenous thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

Rapid enzyme release from acutely infarcted myocardium after early thrombolyic therapy: Washout or reperfusion damage?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

Enzyme tests in the evaluation of thrombolysis in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

Usefulness of a rapid initial increase in plasma creatine kinase activity as a marker of reperfusion during thrombolytic therapy for acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

No-reflow phenomenon during percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

Early and late angiographic findings of the "no-reflow" phenomenon following direct angioplasty as primary treatment for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

Incidence and treatment of 'no-reflow' after percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

Alternation in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

The "no-reflow" phenomenon after temporary coronary occlusion in the dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

The effect of streptokinase on intramyocardial hemorrhage, infarct size, and the no-reflow phenomenon during coronary reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

Reduction in experimental infarct size by recombinant human superoxide dismutase: insights into the pathophysiology of reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

Progressive decreases in coronary vein flow during reperfusion in acute myocardial infarction: clinical documentation of the no reflow phenomenon after successful thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

Proarrhythmic effects of an oxygen-derived free radical generating system on action potentials recorded from guinea pig ventricular myocardium: a possible cause of reperfusion-induced arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

Abnormal electrical activity induced by free radical generating systems in isolated cardiocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

Does reperfusion injury exist in humans?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study. Second Multicenter Thrombolysis Trial of Eminase in

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900417-3

7 January 2021

10.1016/S0735-1097(98)00417-3

Identifiers

DOI

1 reference

3 June 2018

1 reference

3 June 2018